Skip to main content
Circa Group AS logo

Circa Group AS — Investor Relations & Filings

Ticker · CIRCA ISIN · NO0010917594 LEI · 549300TYMT7PQV920R92 OL Manufacturing
Filings indexed 376 across all filing types
Latest filing 2022-05-20 Regulatory Filings
Country NO Norway
Listing OL CIRCA

About Circa Group AS

https://circa-group.com/

Circa Group AS is a renewable chemicals company that develops and commercializes bio-based products. It utilizes a proprietary thermochemical process, Furacell™, to convert non-food, waste cellulosic biomass into advanced biochemicals. The company's portfolio is centered on the platform chemical levoglucosenone (LGO) and its derivatives, most notably the bio-based solvent Cyrene™. Cyrene™ is designed as a safer, more sustainable alternative to traditional, fossil-derived polar aprotic solvents like NMP. Circa aims to produce these biochemicals at an industrial scale, serving various markets, including pharmaceuticals, agrochemicals, and specialty polymers, that are transitioning to greener chemistry. The company is scaling up its manufacturing capabilities through its ReSolute plant project.

Recent filings

Filing Released Lang Actions
CIRCA AND VALMET PARTNER TO INDUSTRIALISE BIOCHEMICALS PRODUCTION
Regulatory Filings Classification · 99% confidence The document is a press release announcing a strategic partnership (Heads of Agreement) between Circa and Valmet to industrialize biochemicals production, specifically mentioning the ReSolute project and future large-scale plants (FC6). This announcement details a significant business development, technology collaboration, and future capital/production plans, but it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific capital change (CAP). It is a general business update concerning strategic alliances and future operational plans. Since it doesn't fit the specific categories like M&A (TAR), Capital (CAP), or Earnings (ER), and it is a formal announcement, the most appropriate classification is the general Regulatory Filings category (RNS), as it serves as a broad announcement of material information not covered by more specific codes. Given the content is a detailed business development announcement rather than a short notice of report publication, RNS is preferred over RPA.
2022-05-20 English
CIRCA OG VALMET INNGÅR PARTNERSKAP FOR Å INDUSTRIALISERE PRODUKSJON AV BIOKJEMIKALIER
Regulatory Filings Classification · 99% confidence The document is a press release dated May 20, 2022, announcing a partnership agreement between Circa and Valmet regarding the industrialization of biochemical production (Furacell™ process). It details strategic goals, project milestones (ReSolute and FC6), and includes quotes from management. This type of announcement, which is a formal communication about a significant business development but is not a full financial report (like 10-K or IR) or a specific regulatory filing like insider trading (DIRS) or dividend notice (DIV), fits best under the general category for regulatory announcements or news releases that don't fit elsewhere. Since it is a formal announcement of a strategic business event, it is classified as a Regulatory Filing (RNS) as the most appropriate general category, although it functions like a press release announcing strategic news.
2022-05-20 Norwegian
CIRCA AND VALMET PARTNER TO INDUSTRIALISE BIOCHEMICALS PRODUCTION
Regulatory Filings Classification · 95% confidence The document is a press release dated May 20, 2022, announcing a strategic partnership (Heads of Agreement) between Circa and Valmet regarding the industrialization of biochemicals production. It details a business development, technology supply agreement, and future project milestones (ReSolute and FC6 plants). This type of announcement, focusing on strategic business relationships, technology collaboration, and future operational plans, does not fit neatly into the specific financial reporting categories (10-K, IR, ER, DIV, etc.). It is a general corporate announcement regarding business strategy and operations. Since it is not a formal regulatory filing like a 10-K or a specific financial report, and it is not explicitly announcing a dividend, management change, or shareholder vote result, the most appropriate classification is the general regulatory/corporate announcement fallback category, RNS, as it serves as a broad communication to the market about significant corporate activity.
2022-05-20 English
CIRCA GROUP AS – INVITATION TO Q1 2022 RESULTS
Report Publication Announcement Classification · 98% confidence The document is a press release titled "CIRCA GROUP AS – INVITATION TO Q1 2022 RESULTS". It explicitly states that the quarterly report and presentation for Q1 2022 will be published on a future date (May 24, 2022) and provides details for an accompanying webinar/conference call. Since the document's primary function is to announce the upcoming release of financial results and an associated call, it fits the definition of a Report Publication Announcement (RPA). It is not the full report (IR or 10-K) nor the transcript of the call (CT), but the announcement of these events. Given the short length and the focus on announcing the publication of reports, RPA is the most appropriate classification.
2022-05-18 Norwegian
CIRCA GROUP AS – INVITATION TO Q1 2022 RESULTS
Report Publication Announcement Classification · 98% confidence The document is titled "CIRCA GROUP AS – INVITATION TO Q1 2022 RESULTS" and explicitly states that the quarterly report and presentation for Q1 2022 "will be published at 07:00 CEST on 24 May 2022." It also announces a subsequent webinar. Since the document's primary function is to announce the upcoming release of the actual financial report (Q1 results) rather than containing the full report itself, it fits the definition of a Report Publication Announcement (RPA). The document length (2050 chars) is also short, supporting the RPA classification over the comprehensive Interim Report (IR) or Earnings Release (ER).
2022-05-18 English
Annual report 2021
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2021' and contains comprehensive sections including CEO reflections, key financial metrics, a Board of Directors report, consolidated financial statements, notes to the financial statements, and an independent auditor's report. It covers the company's performance, strategy, and financial results for the full fiscal year 2021, fitting the definition of an Annual Report (10-K). FY 2021
2022-04-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.